Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Investment Corporation (KIC) is South Korea’s sovereign wealth fund, established in 2005 to manage public funds entrusted by the government and the Bank of Korea. Its mission is to preserve and enhance the long-term purchasing power of South Korea's sovereign assets through diversified investments in global financial markets. As of December 2023, KIC manages $189.4 billion in assets across equities, fixed income, private equity, real estate infrastructure, hedge funds, and other asset classes[1][2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Investment Corporation.